# Filing Detail

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001628280-25-029252
Filing Date
2025-06-04
Accepted
2025-06-04 11:52:14
Documents
8
Period of Report
2025-06-04

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 6-K | form6-kxjune42025.htm | 6-K | 9059
2 | EX-99.1 | ceoretirement-materialch.htm | EX-99.1 | 12066
3 | GRAPHIC | ceoretirement-materialch001.jpg | GRAPHIC | 120477
4 | GRAPHIC | ceoretirement-materialch002.jpg | GRAPHIC | 28429
5 | GRAPHIC | ceoretirement-materialch003.jpg | GRAPHIC | 232451
6 | GRAPHIC | ceoretirement-materialch004.jpg | GRAPHIC | 245335
7 | GRAPHIC | ceoretirement-materialch005.jpg | GRAPHIC | 202561
8 | GRAPHIC | ceoretirement-materialch006.jpg | GRAPHIC | 63514
| Complete submission text file | 0001628280-25-029252.txt |  | 1252741

Mailing Address 1400-145 KING ST. WEST TORONTO Ontario, Canada M5H 1J8
Business Address 1400-145 KING ST. WEST TORONTO Ontario, Canada M5H 1J8 506-232-4400
ORGANIGRAM GLOBAL INC. (Filer) CIK: 0001620737 (see all company filings)

EIN.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 0930
Type: 6-K | Act: 34 | File No.: 001-38885 | Film No.: 251022371
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)